Ligand validation:2HWP

DJK: N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE

DJK is a Ligand Of Interest in 2HWP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2HWP_DJK_B_1345	33%	14%	0.216	0.894	1.64	2.38	3	10	0	0	100%	0.9783
2HWP_DJK_A_1345	27%	13%	0.211	0.86	1.63	2.52	3	10	1	0	100%	0.9783
3LOK_DJK_B_1345	18%	7%	0.251	0.837	1.85	3.04	4	15	4	0	100%	0.9783
4LQM_DJK_A_1101	46%	2%	0.214	0.952	3.22	3.57	11	15	1	0	100%	1
2J5F_DJK_A_3021	23%	6%	0.241	0.862	2.09	3.04	8	13	2	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.